{"disease":{"id":"anaphylaxis","name":"Anaphylaxis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":4},"drugs":{"marketed":[{"drug_id":"diphenylpyraline","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hispril","generic_name":"DIPHENYLPYRALINE","company_name":"GSK","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"diphenylpyraline","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"tripelennamine-citrate","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyribenzamin","generic_name":"TRIPELENNAMINE CITRATE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"tripelennamine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"antazoline","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Phenazoline","generic_name":"ANTAZOLINE","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"antazoline","quality_score":34,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 5 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 12 years of age and older with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"bnt162b6-bivalent-original-omi-ba-4-ba-5","indication_name":"COVID-19 prevention in individuals 6 months through 4 years of age with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any COVID-19 vaccine","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b6 Bivalent (Original/OMI BA.4/BA.5)","generic_name":"bnt162b6-bivalent-original-omi-ba-4-ba-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"vaccine","quality_score":47,"revenue":null,"mechanism":""},{"drug_id":"methapyrilene","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Thenylene","generic_name":"METHAPYRILENE","company_name":"","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B","drug_class":"","quality_score":23,"revenue":null,"mechanism":null},{"drug_id":"epinephrine","indication_name":"Anaphylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Epipen","generic_name":"epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epipen works by stimulating the alpha-1D adrenergic receptor to rapidly increase heart rate, blood pressure, and bronchodilation."},{"drug_id":"lidocaine-hydrochloride-and-epinephrine","indication_name":"Anaphylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"Epinephrine","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Alpha-1D adrenergic receptor","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":80,"revenue":null,"mechanism":"Epinephrine works by stimulating the alpha-1D adrenergic receptor to increase heart rate and blood pressure, and to constrict blood vessels."},{"drug_id":"azatadine","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azatidine","generic_name":"AZATADINE","company_name":"","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"azatadine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clemastine","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tavist","generic_name":"CLEMASTINE","company_name":"","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"clemastine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clemastin","indication_name":"Anaphylaxis Adjunct","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clemastin","company_name":"Technical University of Munich","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 6, Cytochrome P450 2C19, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"epinephrin","indication_name":"Anaphylaxis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Epinephrin","company_name":"United States Naval Medical Center, San Diego","drug_phase":"marketed","molecular_target":"Alpha-1A adrenergic receptor, Alpha-1B adrenergic receptor, Alpha-1D adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":13,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04615065","title":"Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT05112367","title":"Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05135377","title":"Canadian Anaphylaxis Network- Predicting Recurrence After Emergency Presentation for Allergic REaction","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1682,"lead_sponsor_name":"Waleed Alqurashi","has_results":false},{"nct_id":"NCT00852943","title":"Screening Protocol for Genetic Diseases of Allergic Inflammation","phase":"","overall_status":"COMPLETED","enrollment_count":824,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03393091","title":"Perioperative Anaphylaxis in Patients Attending University Hospitals (Egypt - UK).","phase":"","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02028065","title":"A Study to Evaluate the Incidence of Hypersensitivity After Administration of Sugammadex in Healthy Participants (MK-8616-101)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":382,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04290507","title":"Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit","phase":"","overall_status":"COMPLETED","enrollment_count":339,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT06406114","title":"Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05311644","title":"Hymenoptera Venom Immunotherapy: Evaluation of Its Long-term Efficacy at the University Hospital of Angers (EFLOTITA2)","phase":"","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT07328178","title":"Analysis of the Role of IgE Proteoforms in Health and Disease","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"KU Leuven","has_results":false},{"nct_id":"NCT04755881","title":"SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge)","phase":"","overall_status":"TERMINATED","enrollment_count":191,"lead_sponsor_name":"Université de Sherbrooke","has_results":false},{"nct_id":"NCT04475003","title":"Health Literacy Among Caregivers of Children With IgE-mediated Allergy With Risk of Anaphylaxis","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Algemeen Ziekenhuis Maria Middelares","has_results":false},{"nct_id":"NCT03942692","title":"What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT00719719","title":"Cause of Unexplained Anaphylaxis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":115,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03953482","title":"Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis","phase":"","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT07027163","title":"A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis","phase":"","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05696236","title":"Predicting Peanut Anaphylaxis and Reducing Epinephrine","phase":"NA","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT06065137","title":"Standardised Drug Provocation Testing in Perioperative Hypersensitivity","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Antwerp","has_results":false},{"nct_id":"NCT03282929","title":"Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":false},{"nct_id":"NCT07349212","title":"UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ukko Inc","has_results":false},{"nct_id":"NCT03182491","title":"Mechanisms of Anaphylaxis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT05695261","title":"Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Rima Rachid","has_results":false},{"nct_id":"NCT03487315","title":"Major Allergen in Wheat Anaphylaxis in Thai Population","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT04825158","title":"Study of the Role of Hemostasis in Perioperative Anaphylaxis","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT07210320","title":"PK/PD Study of IN-001 Sublingual Spray in Healthy Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Insignis Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07045701","title":"FMXIN002 in Patients at Risk of Anaphylaxis","phase":"PHASE2, PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"Nasus Pharma","has_results":false},{"nct_id":"NCT04207840","title":"Study of Drug Exposure in Systemic Circulation of Primatene Mist by Oral Inhalation, Versus Epinephrine Injection by Intramuscular Injection and ProAir by Oral Inhalation in Healthy Individuals","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Amphastar Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06445374","title":"Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Dr. George Luciuk","has_results":false},{"nct_id":"NCT03406325","title":"Mast Cell Activation Test in Allergic Disease","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Hong Kong Sanatorium & Hospital","has_results":true},{"nct_id":"NCT00890162","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06963411","title":"Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Kokua Pharma Inc.","has_results":false},{"nct_id":"NCT03366298","title":"Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT06205134","title":"Comparative Bioavailability of Intranasal Epinephrine","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Nasus Pharma","has_results":false},{"nct_id":"NCT04696822","title":"Bioavailability of Nasal Epinephrine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Nasus Pharma","has_results":false},{"nct_id":"NCT03149315","title":"Inhibition of Anaphylaxis by Ibrutinib","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Ann & Robert H Lurie Children's Hospital of Chicago","has_results":true}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}